Case of Cardiac Arrest Treated with Extra-Corporeal Life Support after MDMA Intoxication
Pierre Voizeux, Romain Lewandowski, Theresa Daily, Omar Ellouze, Olivier Bouchot, Belaïd Bouhemad, Pierre-Grégoire Guinot
Case Reports in Critical Care January 26, 2020 DOI: 10.1155/2019/7825915 via DOAJ
Summary
AI-generated from the abstractA 22-year-old man who ingested MDMA developed serotonin syndrome, leading to an electrical storm and refractory cardiac arrest. Extracorporeal life support, combined with vasoactive drugs, renal replacement therapy, and mechanical ventilation, successfully managed his hemodynamic instability. His temperature was rapidly regulated, and all hemodynamic support was weaned within the first week of hospitalization. Extracorporeal life support offers advantages in treating hemodynamic instability caused by serotonin syndrome.
Study at a glance
| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 22-year-old man with serotonin syndrome due to MDMA ingestion |
| Interventions | Extra-corporeal life support vasoactive drugs renal replacement therapy mechanical ventilation |
| Duration | First week of hospitalisation |
| Citations | 7 |
| Key finding | Extracorporeal life support effectively managed hemodynamic instability in a patient with serotonin syndrome-induced refractory cardiac arrest. |
Abstract
Objective. To describe the case of a patient who developed a serotonin syndrome due to a 3,4-methylenedioxymethamphetamine ingestion with electrical storm and refractory cardiac arrest. Design. Case report. Study Selection. ICU of a university hospital. Patient. A 22-year-old man transferred to the emergency room with hyperthermia, tremors, and mydriasis presented a cardiac arrest due to ventricular fibrillation. Interventions. We implemented extra-corporeal life support combined with vasoactive drugs. Later, he also benefited from renal replacement therapy and mechanical ventilation. Measurements and Main Results. We were able to rapidly regulate our patient’s temperature and we weaned all hemodynamic support in the first week of hospitalisation. Conclusion. Extracorporeal life support has several advantages as part of the management of hemodynamic instability induced by serotonin syndrome.